Curriculum
Occupazione Dal 1 aprile 2025 Ricercatore Tenure Track (RTT) presso il Dipartimento di Medicina Traslazionale e di Precisione, Sapienza Università di Roma
Dal 15 giugno 2018 al 31 marzo 2025 Dirigente Medico di I livello in Ematologia, Azienda Ospedaliera
Universitaria Policlinico Umberto I di Roma. Attività clinica e di ricerca nell’ambito delle malattie
del sangue, in particolare delle malattie emorragiche e trombotiche della coagulazione
Esperienza professionale Attività clinica e di ricerca presso l’Istituto di Ematologia, “Sapienza” Università di Roma,
Policlinico Umberto I, Roma. (DAI Ematologia, Oncologia e Dermatologia; UOC Ematologia)
Lavoro o posizione ricoperti Dal 1 settembre 2017 al 14 giugno 2018 medico frequentatore presso la Cattedra di Ematologia,
“Sapienza” Università di Roma.
Dal 1 settembre 2012 al 31 agosto 2017 ricercatore a tempo determinato di tipo A.
Da febbraio 2012 ad agosto 2012 medico frequentatore presso la Cattedra di Ematologia,
“Sapienza” Università di Roma.
Da febbraio 2009 a febbraio 2012 assegnista di ricerca. Tale attività è stata svolta da febbraio
2009 a giugno 2009 presso la Cattedra di Ematologia, “Sapienza” Università di Roma; da
luglio 2009 a dicembre 2009 presso il New York Presbiterian Hospital, Weill Cornell Medical
College, NY, Department of Pediatrics, Hemophilia Program, Direttore Prof. Donna Di Michele;
da gennaio 2010 a febbraio 2011 presso il Mountain States Regional Hemophilia and
Thrombosis Center, University of Colorado, Direttore Marilyn Manco-Johnson; da marzo 2011
a gennaio 2012 presso la Cattedra di Ematologia, “Sapienza” Università di Roma.
Principali attività e responsabilità Attività clinica, di laboratorio e di ricerca clinica e di laboratorio nell’ambito
dell’Emostasi e della Trombosi.
Attività di tutor nei confronti di dottorandi in Scienze Ematologiche e laureandi in Medicina e
Chirurgia e specializzandi in Ematologia
Attività didattica:
-Insegnamento di INFERMIERISTICA CLINICA IN AREA SPECIALISTICA (1034958), modulo
Malattie del Sangue MED/15 e modulo Oncologia MED/06, nel Corso di Laurea Y
Infermieristica, Roma S. Raffaele Pisana, Dipartimento Scienze Chirurgiche dal 01-11-2013 al
31-10-2014
-Insegnamento di INFERMIERISTICA CLINICA IN AREA SPECIALISTICA (1034958), modulo
Malattie del Sangue MED/15 e modulo Oncologia MED/06, nel Corso di Laurea Y
Infermieristica, Roma S. Raffaele Pisana, Dipartimento Scienze Chirurgiche dal 01-11-2014 al
31-10-2015
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2009,
Facoltà di Farmacia e Medicina dal 01-11-2014 al 31-10-2015
-Insegnamento di Patologia Integrata IV, modulo Malattie del Sangue MED/15 nel Corso di
Laurea di Medicina e Chirurgia B della facoltà di Medicina e Odontoiatria dal 01-11-2014 al 31-
10-2015 Insegnamento di Emostasi nel Master di II livello in Ematologia Pediatrica (10920),
Facoltà di Farmacia e Medicina dal 01-11-2014 al 31-10-2015
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2015,
Facoltà di Farmacia e Medicina dal 01-11-2014 al 31-10-2015
-Insegnamento di INFERMIERISTICA CLINICA IN AREA SPECIALISTICA (1034958), modulo
Malattie del Sangue MED/15 , nel Corso di Laurea X Infermieristica, Dipartimento di Sanità
Pubblica e Malattie Infettive dal 01-11-2014 al 31-10-2015
-Insegnamento di Patologia Integrata IV, modulo Malattie del Sangue MED/15 nel Corso di
Laurea di Medicina e Chirurgia B della facoltà di Medicina e Odontoiatria dal 01-11-2015 al 31-
10-2016
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2009,
Facoltà di Farmacia e Medicina dal 01-11-2015 al 31-10-2016
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2015,
Facoltà di Farmacia e Medicina dal 01-11-2015 al 31-10-2016
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2015,
Facoltà di Farmacia e Medicina dal 01-11-2016 a oggi
-Insegnamento di Emostasi nella Scuola di Specializzazione in Ematologia, ordinamento 2009,
Facoltà di Farmacia e Medicina dal 01-11-2016 a oggi
-Insegnamento di Patologia Integrata IV, modulo Malattie del Sangue MED/15 nel Corso di
Laurea di Medicina e Chirurgia B della facoltà di Medicina e Odontoiatria dal 01-11-2016 al 31-
10-2017
-Insegnamento di ematologia nel corso di Clinical Medicine II, Corso di medicina e Chirurgia in
inglese, Università Campus Biomedico AA 2021-2022 e 2022-2023 -
- insegnamento di Ematologia nel Corso di Laurea Infermieristica D, sede Policlinico Umberto I
AA 2023-2024
-Insegnamento di Ematologia nel Corso di Laurea in Ostetricia ‘A’, Facolta’ di Medicina e
Odontoiatria sede Policlinico Umberto I AA 2023-2024
- Docente nell’ambito della Progettualità di cooperazione internazionale "Potenziamento dei
Centri clinici per la diagnosi e cura delle malattie emorragiche congenite e delle
emoglobinopatie in Palestina (HAEMO_PAL)", coordinata dal Centro Nazionale Sangue -
Istituto Superiore di Sanità
Nome e indirizzo del datore di lavoro Azienda Ospedaliero Universitaria Policlinico Umberto I, Roma
Tipo di attività o settore Ematologia
Istruzione e Formazione e Titoli
Date e Titolo della qualifica rilasciata Dicembre 2017: conseguimento dell’Abilitazione Scientifica Nazionale a Professore di II fascia per il settore concorsuale 06/D3 Malattie del Sangue, Oncologia, Reumatologia
Giugno 2008: conseguimento del titolo di Dottore di Ricerca in Scienze Ematologiche presso “Sapienza” Università di Roma (XIX Ciclo dei Dottorati di Ricerca, “Sapienza Università di Roma, Novembre 2003 – Novembre 2007)
Novembre 2003: conseguimento della specializzazione in Ematologia (I scuola di specializzazione “Sapienza” Università di Roma, Novembre 1999 – Novembre 2003) con voti 70/70 e lode
Giugno 2000: conseguimento all’abilitazione della professione medica.
Novembre 1999: conseguimento della Laurea in Medicina e Chirurgia (“Sapienza” Università di Roma) con voti 110/110 e lode
Luglio 1993: conseguimento della maturità classica con voti 60/60
Principali tematiche/competenze professionali possedute Ambito ematologico specialmente non oncologico; competenze nel settore dell’Emostasi, della Trombosi, delle Piastrinopenie, delle Sindromi Mieloproliferative Croniche Ph1neg (in particolare Trombocitemia Essenziale)
Nome e tipo d'organizzazione erogatrice dell'istruzione e formazione “Sapienza” Università di Roma
Capacità e competenze personali
Madrelingua(e) Italiano
Altra(e) lingua(e) Inglese
Autovalutazione Comprensione Parlato Scritto
Livello europeo (*) Ascolto Lettura Interazione orale Produzione orale
Lingua inglese C1 B2 C1 B2 B2
(*) Quadro comune europeo di riferimento per le lingue
Capacità e competenze sociali Buono spirito di gruppo e buone capacità di comunicazione. Capacità di adeguamento ad ambienti multiculturali
Capacità e competenze organizzative Buone capacità organizzative sia nell’ambito dell’attività clinica che di ricerca .
Capacità e competenze informatiche Buona conoscenza dei programmi OfficeTM (WordTM, ExcelTM, PowerPointTM)
Ulteriori informazioni
- Consigliere nel Consiglio Direttivo dell’AICE da novembre 2020- al novembre 2023
- Membro della Commissione Linee Guida dell’AICE
- Membro della Commissione Studi Clinici dell’AICE
- Membro della Commissione Attività Formative della SISET
- Membro del working group GIMEMA Anemie e Piastrinopenie
- Cofondatore e membro della associazione Internazionale International Fibrinogen Physicians and Patients Association
- Relatore a >150 convegni di carattere scientifico in Italia o all'estero
- Organizzatore di 10 convegni di carattere scientifico in Italia
- Revisore di >100 articoli su riviste internazionali
- Partecipazione attiva a molteplici registri e protocolli di ricerca nazionali e internazionali.
Partecipazione ai seguenti progetti di ricerca:
Progetto di Ricerca (su fondi della ricerca scientifica di ateneo, Facoltà di Medicina e Chirurgia,
Università degli Studi La Sapienza di Roma) dal titolo: "Familiarità per malattie linfoproliferative in
pazienti affetti da Leucemia Linfatica Cronica: epidemiologia, caratteristiche cliniche e
prognostiche" dal 12-06-2002 al 12-06-2003
Progetto di Ricerca (su fondi della ricerca scientifica di ateneo, Facoltà di Medicina e Chirurgia,
Università degli Studi La Sapienza di Roma) dal titolo: "Tumori secondari nei pazienti affetti da
leucemia linfatica cronica (LLC): caratteristiche epidemiologiche, cliniche e correlazione con la
terapia."dal 03-06-2003 al 04-06-2004
Progetti INSIGHT/RISE, promossi dal Dpt. of Pediatric Hematology, Emma children's Hospital,
Academic Medical Center, Amsterdam, the Netherlands. dal 2011 al 2020
Progetto di Ricerca (su fondi della ricerca scientifica di ateneo, Sapienza Università di Roma)
dal titolo: "Identification of BCR/ABL-like acute lymphoblastic leukemia patients by using the
expression levels of 9 genes evaluated by quantitative PCR: a diagnostic model." dal 08-05-2014
al 05-05-2016
Proponente e coordinatrice nazionale dello studio “Valutazione retrospettiva del fenotipo
clinico e del trattamento nei pazienti affetti da difetti del fibrinogeno”, approvato dal Consiglio
Direttivo e dall’Assemblea Societaria dell'Associazione Italiana Centri Emofilia e condotto sotto
l’egida di tale Società Scientifica. dal 01-03-2015 a oggi.
Co-investigator di ~50 studi sponsorizzati e principal investigator di ~20
studi non sponsorizzati
Conseguimento del premio "1st abstract prize" nell'ambito del 9° Congresso della "European
Association for Haemophilia and Allied Disorders (EAHAD)", 2016, per l'abstract dal titolo
"Investigation of possible correlation between clinical and laboratory phenotype in congenital
FXI deficiency: results from a single center."
Vincitrice di un grant di 10.000 E per il 2024 nell’ambito del Bando Centro Studi e Ricerche di
SISET con il progetto “Acquired coagulopathies in the course of hematological
diseases: a retrospective/prospective registry”
Autorizzo il trattamento dei miei dati personali ai sensi del Decreto Legislativo 30 giugno 2003, n. 196 "Codice in materia di protezione dei dati personali".
Firma
Data Cristina Santoro
Roma, 17 febbraio 2025
Pubblicazioni in riviste internazionali
1) Acquila M, Pasino M, Santoro C, Lanza T, Molinari AC, Bottini F, Bicocchi MP. Germ-line origin of intron 1 inversion in two haemophilia A families. Haemophilia. 2003;9:717-20.
2) Mazzucconi MG, Redi R, Bernasconi S, Bizzoni L, Dragoni F, Latagliata R, Santoro C, Mandelli F. A long-term study of young patients with essential thrombocythemia treated with anagrelide. Haematologica. 2004;89(11):1306-13.
3) L. Bizzoni, M.G. Mazzucconi, M. Gentile, C. Santoro, S. Bernasconi, F. Chiarotti, R. Foà and F. Mandelli . Idiopathic thrombocytopenic purpura (ITP) in the elderly: clinical course in 178 patients. Eur J Haematol. 2006;76(3):210-216.
4) Giona F, Palumbo G, Amendola A, Santoro C, Mazzuconi MG. Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: effects of enzyme replacement therapy (ERT). J Thromb Haemost. 2006;4(8):1831-3
5) Valerio De Stefano, Tommaso Za, Elena Rossi, Elena Elli, Alessandro M. Vannucchi, Marco Ruggeri, Caterina Micò, Nicola Vianelli, Rossella R. Cacciola, Alessia Tieghi, Cristina Santoro, Enrico M. Pogliani, Paola Guglielmelli, Lisa Pieri, Francesca Scognamiglio, Francesco Rodeghiero, Guido Finazzi, Luigi Gugliotta, Giuseppe Leone, Tiziano Barbui, for the GIMEMA CMD-Working Party. Recurrent Venous Thrombosis in patients with Policythemia Vera and Essential Thrombocythemia. Clinical Leukemia, Vol.1, No 6, 339-344, 2007
6) Ruggeri M, Rodeghiero F, Tosetto A, Castaman G, Scognamiglio F, Finazzi G, Delaini F, Micò C, Vannucchi AM, Antonioli E, De Stefano V, Za T, Gugliotta L, Tieghi A, Mazzucconi MG, Santoro C, Barbui T; Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) Chronic Myeloproliferative Diseases Working Party. Postsurgery outcomes in patients with polycythemia vera and essential thrombocythemia: a retrospective survey. Blood. 2008;111(2):666-71.
7) Santoro C, Rago A, Biondo F, De Propris MS, De Vellis A, Guarini A, Pignoloni P, Mazzucconi MG. Efficacy of rituximab treatment in postpartum acquired haemophilia A. Haemophilia. 2008;14(1):147-9
8) De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Marchioli R, Leone G, Barbui T; GIMEMA CMD-Working Party. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments. Haematologica. 2008;93(3):372-80.
9) Iorio A, Oliovecchio E, Morfini M, Mannucci PM; Association of Italian Hemophilia Centres Directors.Collaborators (68) Contino L, Accorsi A, Ciavarella N, Schiavoni M, Scaraggi FA, Rodorigo G, Valdré L, Targhetta R, Tagariello G, Radossi P, Musso R, Cultrera D, Muleo G, Iannacaro P, Biasioli C, Testa S, Alatri A, Vincenzi D, Scapoli G, Morfini M, Molinari AC, Boeri E, Caprino D, Mariani G, Lapecorella M, Carloni MT, Cantori I, Mannucci PM, Santagostino E, Gringeri A, Federici AB, Marietta M, Pedrazzoli P, Di Minno G, Coppola A, Perricone C, Schiavulli M, Rocino A, Berrettini M, Zanon E, Mancuso G, Siragusa S, Malato A, Saccullo G, Tagliaferri A, Rivolta F, Iorio A, Oliovecchio E, Ferrante F, Dragani A, Rossi A, Mancino A, Albertini P, Macchi S, D'Inca M, De Rossi G, Luciani M, Landolfi R, Mazzucconi MG, Santoro C, Piseddu G, Carla Schinco P, Rossetti G, Barillari G, Feola G, Gandini G, Franchini M, Castaman G.
Italian Registry of Haemophilia and Allied Disorders. Objectives, methodology and data analysis. Haemophilia. 2008;14(3):444-53.
10) Tagliaferri A, Franchini M, Coppola A, Rivolta GF, Santoro C, Rossetti G, Feola G, Zanon E, Dragani A, Iannaccaro P, Radossi P, Mannucci PM. Effects of secondary prophylaxis started in adolescent and adult haemophiliacs. Haemophilia. 2008;14(5):945-51.
11) Franchini M, Coppola A, Molinari AC, Santoro C, Schinco P, Speciale V, Tagliaferri A. Forum on: the role of recombinant factor VIII in children with severe haemophilia A. Haemophilia. 2009;15(2):578-86.
12) Santoro C, Iorio A, Ferrante F, Pallotta A, Pignoloni P, Biondo F, Agnelli G, Mazzucconi MG. Performance of recalibrated ReFacto laboratory standard in the measurement of FVIII plasma concentration via the chromogenic and one-stage assays after infusion of recalibrated ReFacto (B-domain deleted recombinant factor VIII). Haemophilia. 2009;15(3):779-87.
13) Tagariello G, Iorio A, Santagostino E, Morfini M, Bisson R, Innocenti M, Mancuso ME, Mazzucconi MG, Pasta GL, Radossi P, Rodorigo G, Santoro C, Sartori R, Scaraggi A, Solimeno LP, Mannucci PM; Italian Association Hemophilia Centre (AICE).Comparison of the rates of joint arthroplasty in patients with severe factor VIII and IX deficiency: an index of different clinical severity of the 2 coagulation disorders. Blood. 2009;114(4):779-84.
14) De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Vianelli N, Guglielmelli P, Pieri L, Scognamiglio F, Cacciola E, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Leone G, Barbui T; for the GIMEMA Chronic Myeloproliferative Neoplasms Working Party. Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation. Ann Hematol 2010;89(2):141-6.
15) Latagliata R, Rago A, Spadea A, Santoro C, Carmosino I, Breccia M, Napoleone L, Fama A, Biondo F, Volpicelli P, Vozella F, Stefanizzi C, Petti MC, Alimena G, Mazzucconi MG. Decisional flow with a scoring system to start platelet-lowering treatment in patients with essential thrombocythemia: long-term results. Int J Hematol 2009;90(4):486-91
16) De Stefano V, Za T, Rossi E, Vannucchi AM, Ruggeri M, Elli E, Micò C, Tieghi A, Cacciola RR, Santoro C, Gerli G, Guglielmelli P, Pieri L, Scognamiglio F, Rodeghiero F, Pogliani EM, Finazzi G, Gugliotta L, Leone G, Barbui T. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycithemia vera and essential thrombocythemia. American Journal of hematology 2010;85(2):97-100.
17) Coppola A, Santoro C, Tagliaferri A, Franchini M, DI Minno G. Understanding inhibitor development in haemophilia A: towards clinical prediction and prevention strategies. Haemophilia. 2010;16 Suppl 1:13-9.
18) Tagliaferri A, Rivolta GF, Iorio A, Oliovecchio E, Mancuso ME, Morfini M, Rocino A, Mazzucconi MG, Franchini M; Italian Association of Hemophilia Centers, Ciavarella N, Scaraggi A, Valdrè L, Tagariello G, Radossi P, Muleo G, Iannaccaro PG, Biasoli C, Vincenzi D, Serino ML, Linari S, Molinari C, Boeri E, La Pecorella M, Carloni MT, Santagostino E, Di Minno G, Coppola A, Rocino A, Zanon E, Spiezia L, Di Perna C, Marchesini M, Marcucci M, Dragani A, Macchi S, Albertini P, D'Incà M, Santoro C, Biondo F, Piseddu G, Rossetti G, Barillari G, Gandini G, Giuffrida AC, Castaman G.Mortality and causes of death in Italian persons with haemophilia, 1990-2007.Haemophilia. 2010;16(3):437-46.
19) Santoro C, Rago A, Biondo F, Conti L, Pulcinelli F, Laurenti L, Perrone MP, Baldacci E, Leporace A, Mazzucconi MG. Prevalence of allo-immunization anti-HLA and anti-integrin alphaIIbbeta3 in Glanzmann Thromboasthenia patients. Haemophilia. 2010;16(5):805-12.
20) Santoro C, Goldberg I, Bridey F, Figgie MP, Karila-Israel D, Haviland K, Mackenzie CR, Dimichele DM. Successful hip arthroplasty in an adult male with severe factor XI deficiency using Hemoleven(®), a factor XI concentrate. Haemophilia. 2011;17(5):777-82
21) Giampaolo A, Abbonizio F, Puopolo M, Arcieri R, Mannucci PM; Italian Association of Haemophilia Centres, Hassan HJ, Accorsi A, Ettorre PC, Schiavoni M, Palareti G, Rodorigo G, Valdré L, Amaddii G, Billio A, Notarangelo L, Iannacaro P, Muleo P, Biasioli C, Rossi V, Alatri A, Testa S, Vincenzi D, Scapoli G, Morfini M, Molinari AC, Lapecorella M, Mariani G, Baudo F, Caimi MT, Federici AB, Gringeri A, Mannucci PM, Santagostino E, Marietta M, Coppola A, Di Minno G, Perricone C, Schiavulli M, Miraglia E, Rocino A, Zanon E, Gagliano F, Mancuso G, Siragusa S, Rivolta F, Tagliaferri A, Gamba G, Iorio A, Oliovecchio E, Dragani A, Arbasi MC, Albertini P, Mancino A, Lombardo VT, Latella C, D'Incà M, Landolfi Raffaele, Biondo Francesca, Mazzucconi MG, Santoro Cristina, Mameli AL, Piseddu G, Schinco PC, Messina M, Rossetti G, Barillari G, Feola G, Franchini M, Gandini G, Castaman G, Rodeghiero F. Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. Transfus Med. 2011 Aug;21(4):280-4
22) Santoro C, Hsu F, Dimichele DM. Haemostasis prophylaxis using single dose desmopressin acetate and extended use epsilon aminocaproic acid for adenotonsillectomy in patients with type 1 von Willebrand disease. Haemophilia. 2012;18(2):200-4
23) Tagliaferri A, Di Perna C, Santoro C, Schinco P, Santoro R, Rossetti G, Coppola A, Morfini M, Franchini M; on behalf of the Italian Association of Hemophilia Centers.Cancers in Patients with Hemophilia: a Retrospective Study from the Italian Association of Hemophilia Centers. J Thromb Haemost. 2012 Jan;10(1):90-5.
24) Biondo F, Matturro A, Santoro C, Leporace A, D'Elia G, Baldacci E, Pignoloni P, Pulsoni A, Foà R, Mazzucconi M. Remission of acquired von Willebrand syndrome after successful treatment of gastric MALT lymphoma. Haemophilia. 2012;18(1):e34-5.
25) Siboni SM, Mannucci PM, Gringeri A, Franchini M, Tagliaferri A, Ferretti M, Tradati FC, Santagostino E, von Mackensen S; Italian Association of Haemophilia Centres (AICE). Health status and quality of life of elderly persons with severe hemophilia born before the advent of modern replacement therapy. J Thromb Haemost. 2009; 7(5):780-6.
26) Mannucci PM, Franchini M, Castaman G, Federici AB; AICE (Italian Association of Haemophilia Centres). Evidence-based recommendations on the treatment of von Willebrand disease in Italy. Blood Transfusion 2009; 7 (2): 117-26.
27) Rocca A, Pizzinelli S, Oliovecchio E, Santagostino E, Rocino A, Iorio A; Italian ad hoc study group. Replacement therapy with recombinant factor IX. A multicentre evaluation of current dosing practices in Italy. Blood Transfus. 2011;9(1):60-9.
28) von Mackensen S, Gringeri A, Siboni SM, Mannucci PM; Italian Association Of Haemophilia Centres (AICE).Health-related quality of life and psychological well-being in elderly patients with haemophilia. Haemophilia. 2012;18(3):345-52
29) Baudo F, Collins P, Huth-Kühne A, Lévesque H, Marco P, Nemes L, Pellegrini F, Tengborn L, Knoebl P; EACH2 registry contributors. Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. Blood. 2012;120(1):39-46.
30) Collins P, Baudo F, Knoebl P, Lévesque H, Nemes L, Pellegrini F, Marco P, Tengborn L, Huth-Kühne A; EACH2 registry collaborators. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). Blood. 2012;120(1):47-55..
31) Knoebl P, Marco P, Baudo F, Collins P, Huth-Kühne A, Nemes L, Pellegrini F, Tengborn L, Lévesque H; EACH2 Registry Contributors. Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). J Thromb Haemost. 2012;10(4):622-31.
32) Tengborn L, Baudo F, Huth-Kühne A, Knoebl P, Lévesque H, Marco P, Pellegrini F, Nemes L, Collins P; EACH2 registry contributors. Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. BJOG. 2012;119(12):1529-37.
33) Santoro C, Baldacci E, Mercanti C, Mazzucconi MG Tailored versus Standard Dose Prophylaxis in Children with Hemophilia A. Semin Thromb Hemost. 2013 Oct;39(7):711-22
34) Coppola A, Santoro C, Franchini M, Mannucci C, Mogavero S, Molinari AC, Schinco P, Tagliaferri A, Santoro RC. Emerging Issues on Comprehensive Hemophilia Care: Preventing, Identifying, and Monitoring Age-Related Comorbidities. Semin Thromb Hemost. 2013 Oct;39(7):794-802
35) Santoro Cristina, Biondo Francesca, Baldacci Erminia, De Propris Maria Stefania, Guarini Anna, Paoloni Francesca, Foà Roberto, Mazzucconi Maria Gabriella. Rituximab in previously treated primary immune thrombocytopenia (pITP) patients: evaluation of short- and long-term efficacy and safety. Acta Haematol. 2013;132(1):24-29.
36) Montanaro M, Latagliata R, Cedrone M, Spadea A, Rago A, Di Giandomenico J, Spirito F, Porrini R, De Muro M, Leonetti SC, Villivà N, De Gregoris C, Breccia M, Montefusco E, Santoro C, Cimino G, Majolino I, Mazzucconi MG, Alimena G, Andriani A. Thrombosis and survival in essential thrombocythemia: a regional study of 1,144 patients. Am J Hematol. 2014 May;89(5):542-6.
37) Abbonizio F, Giampaolo A, Coppola A; Italian Association of Haemophilia Centres (AICE), Arcieri R, Hassan HJ. Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy.Haemophilia. 2014;20(4):e243-50.
38) Ruggeri M, Tosetto A, Palandri F, Polverelli N, Mazzucconi MG, Santoro C, Gaidano G, Lunghi M, Zaja F, De Stefano V, Sartori R, Fazi P, Rodeghiero F; The Gruppo Italiano Malattie EMatologiche dell'Adulto (GIMEMA) AnemiaThrombocytopenias Working Party. GIMEMA Study ITP0311. Thrombotic Risk In Patients With Primary Immune Thrombocytopenia Is Only Mildly Increased And Explained By Personal And Treatment-Related Risk Factors. J Thromb Haemost. 2014 Aug;12(8):1266-73.
39) Morfini M, Marchesini E, Paladino E, Santoro C, Zanon E, Iorio A. Pharmacokinetics of plasma-derived vs. recombinant FVIII concentrates: a comparative study. Haemophilia. 2015 Mar;21(2):204-9.
40) Rocino A, Coppola A, Franchini M, Castaman G, Santoro C, Zanon E, Santagostino E, Morfini M; Italian Association of Haemophilia Centres (AICE) Working Party. Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. Blood Transfus. 2014 Oct;12(4):575-98.
41) Mazzucconi MG, De Sanctis V, Alfò M, Amendolea MA, Conti L, Santoro C, Baldacci E, Peraino M, Masala C.Maternal thrombophilia and adverse pregnancy outcome: a case-control study.
Acta Haematol. 2015;133(2):242-8.
42) Santoro C, Di Mauro R, Baldacci E, De Angelis F, Abbruzzese R, Barone F, Bochicchio RA, Ferrara G, Guarini A, Foà R, Mazzucconi MG. Bleeding phenotype and correlation with factor XI (FXI) activity in congenital FXI deficiency: results of a retrospective study from a single centre.
Haemophilia. 2015 Jul;21(4):496-501.
43) Liu Y, Zhang L, Santoro C, Song J, Rodriguez A, Wang L. Rituximab for treating inhibitors in people with inherited severe hemophilia. Cochrane Database Syst Rev. 2015 Apr 4;4:CD010810.
44) Tagliaferri A, Feola G, Molinari AC, Santoro C, Rivolta GF, Cultrera DB, Gagliano F, Zanon E, Mancuso ME, Valdré L, Mameli L, Amoresano S, Mathew P, Coppola A; POTTER Study Group. Benefits of prophylaxis versus on-demand treatment in adolescents and adults with severe haemophilia A: the POTTER study. Thromb Haemost. 2015 Jul;114(1):35-45
45) Civaschi E, Klersy C, Melazzini F, Pujol-Moix N, Santoro C, Cattaneo M, Lavenu-Bombled C, Bury L, Minuz P, Nurden P, Cid AR, Cuker A, Latger-Cannard V, Favier R, Nichele I, Noris P; European Haematology Association - Scientific Working Group on Thrombocytopenias and Platelet Function Disorders. Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders. Br J Haematol. 2015 Aug;170(4):559-63
46) Asselta R, Robusto M, Platé M, Santoro C, Peyvandi F, Duga S. Molecular characterization of 7 patients affected by dys- or hypo-dysfibrinogenemia: Identification of a novel mutation in the fibrinogen Bbeta chain causing a gain of glycosylation. Thromb Res. 2015 Jul;136(1):168-74
47) Silvia Riva, Ilaria Cutica, Caspar Krampe, Laura Reinecke, William Russell-Edu, Cristina Santoro, Angiola Rocino, Elena Santagostino, vega rusconi, Gabriella Pravettoni .A cohort pilot study on HIV-associated neuropsychological impairments in haemophilia patients. Front Hum Neurosci. 2015 Jun 2;9:313
48) Franchini Massimo, Castaman Giancarlo, Coppola Antonio, Santoro Cristina, Zanon Ezio, Di Minno Giovanni, Morfini Massimo, Santagostino Elena, Rocino Angiola. Acquired Inhibitors of clotting factors: AICE recommendations for diagnosis and management. Blood Transfus. 2015 Jun 24:1-16.
49) Davide Matino, Marco Gargaro, Elena Santagostino, Matteo N.D. Di Minno, Giancarlo Castaman, Massimo Morfini, Angiola Rocino, Maria E. Mancuso, Giovanni Di Minno, Antonio Coppola, Vincenzo N. Talesa, Claudia Volpi, Carmine Vacca, Ciriana Orabona, Rossana Iannitti, Maria G. Mazzucconi, Cristina Santoro, Antonella Tosti, Sara Chiappalupi, Guglielmo Sorci, Giuseppe Tagariello, Donata Belvini, Paolo Radossi, Raffaele Landolfi, Dietmar Fuchs, Louis Boon, Matteo Pirro, Emanuela Marchesini, Ursula Grohmann, Paolo Puccetti, Alfonso Iorio, and Francesca Fallarino. IDO1 suppresses inhibitor development in hemophilia A treated with factor VIII. J Clin Invest Accepted: 2015 Oct 1;125(10):3766-81.
50) Eckhardt CL, Loomans JI, van Velzen AS, Peters M, Mauser-Bunschoten EP, Schwaab R, Mazzucconi MG, Tagliaferri A, Siegmund B, Reitter-Pfoertner SE, van der Bom JG, Fijnvandraat K; INSIGHT Study Group. Inhibitor development and mortality in non-severe hemophilia A. J Thromb Haemost. 2015 Jul;13(7):1217-25
51) Franchini M, Di Perna C, Santoro C, Castaman G, Siboni SM, Zanon E, Linari S, Gresele P, Pasca S, Coppola A, Santoro R, Napolitano M, Ranalli P, Tagliaferri A; Italian Association of Haemophilia Centres. Cancers in Patients with von Willebrand Disease: A Survey from the Italian Association of Haemophilia Centres. Semin Thromb Hemost. 2016 Feb;42(1):36-41.
52) Andriani A, Latagliata R, Anaclerico B, Spadea A, Rago A, Di Veroli A, Spirito F, Porrini R, De Muro M, Crescenzi Leonetti S, Villivà N, De Gregoris C, Montefusco E, Polverelli N, Santoro C, Breccia M, Cimino G, Majolino I, Mazzucconi MG, Vianelli N, Alimena G, Montanaro M, Palandri F. Spleen enlargement is a risk factor for thrombosis in essential thrombocythemia: Evaluation on 1,297 patients. Am J Hematol. 2016 Mar;91(3):318-21.
53) Zaja F, Barcellini W, Cantoni S, Carpenedo M, Caparrotti G, Carrai V, Di Renzo N, Santoro C, Di Nicola M, Veneri D, Simonetti F, Liberati AM, Ferla V, Paoloni F, Crea E, Volpetti S, Tuniz E, Fanin R. Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study. Am J Hematol. 2016 May;91(5):E293-5.
54) Franchini M, Santoro C, Coppola A. Inhibitor incidence in previously untreated patients with severe haemophilia B: a systematic literature review. Thromb Haemost. 2016 Jul 4;116(1):201-3
55) Gugliotta L, Iurlo A, Gugliotta G, Tieghi A, Specchia G, Gaidano G, Scalzulli PR, Rumi E, Dragani A, Martinelli V, Santoro C, Randi ML, Tagariello G, Candoni A, Cattaneo D, Ricco A, Palmieri R, Liberati MA, Langella M, Rago A, Bergamaschi M, Monari P, Miglio R, Santoro U, Cacciola R, Rupoli S, Mastrullo L, Musto P, Mazzucconi MG, Vignetti M, Cortelezzi A, Vianelli N, Martino B, De Stefano V, Passamonti F, Vannucchi AM; Registro Italiano Trombocitemie RIT. Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms. Leuk Res. 2016 Jul;46:18-25.
56) Santoro C, Massaro F, Venosi S, Capria S, Baldacci E, Foà R, Mazzucconi MG. Severe Thrombotic Complications in Congenital Afibrinogenemia: A Pathophysiological and Management Dilemma. Semin Thromb Hemost. 2016 Jul;42(5):577-82
57) Coppola A, Marrone E, Conca P, Cimino E, Mormile R, Baldacci E, Santoro C. Safety of Switching Factor VIII Products in the Era of Evolving Concentrates: Myths and Facts. Semin Thromb Hemost. 2016 Jul;42(5):563-76.
58) Efficace F, Mandelli F, Fazi P, Santoro C, Gaidano G, Cottone F, Borchiellini A, Carpenedo M, Simula MP, Di Giacomo V, Bergamaschi M, Vincelli ID, Rodeghiero F, Ruggeri M, Scaramucci L, Rambaldi A, Cascavilla N, Forghieri F, Petrungaro A, Ditonno P, Caocci G, Cirrincione S, Mazzucconi MG. Health-related quality of life and burden of fatigue in patients with primary immune thrombocytopenia by phase of disease. Am J Hematol. 2016 Oct;91(10):995-1001
59) van Velzen AS, Eckhardt CL, Streefkerk N, Peters M, Hart DP, Hamulyak K, Klamroth R, Meijer K, Nijziel M, Schinco P, Yee TT, van der Bom JG, Fijnvandraat K; INSIGHT study group. The incidence and treatment of bleeding episodes in non-severe haemophilia A patients with inhibitors. Thromb Haemost. 2016 Mar;115(3):543-50.
60) Mazzucconi MG, Santoro C, Baldacci E, De Angelis F, Chisini M, Ferrara G, Volpicelli P, Foà R. TPO-RAs in pITP: description of a case series and analysis of predictive factors for response. Eur J Haematol. 2017 Mar;98(3):242-249.
61) Marangon M, Vianelli N, Palandri F, Mazzucconi MG, Santoro C, Barcellini W, Fattizzo B, Volpetti S, Lucchini E, Polverelli N, Carpenedo M, Isola M, Fanin R, Zaja F. Rituximab in immune thrombocytopenia: gender, age, and response as predictors of long-term response. Eur J Haematol. 2017;98(4):371-37.
62) Coppola A, D'Ausilio A, Aiello A, Amoresano S, Toumi M, Mathew P, Tagliaferri A; Potter Study Group. Cost-effectiveness analysis of late prophylaxis vs. on-demand treatment for severe haemophilia A in Italy. Haemophilia. 2017;23(3):422-429.
63) Loomans JI, Eckhardt CL, Reitter-Pfoertner SE, Holmström M, Laros van Gorkom B, Leebeek FW, Santoro C, Haya S, Meijer K, Nijziel MR, Van der Bom JG, Fijnvandraat K. Mortality caused by intracranial bleeding in non-severe hemophilia A patients. J Thromb Haemost. 2017;15(6):1115-1122.
64) Orsini S, Noris P, Bury L, Heller PG, Santoro C, Kadir RA, Butta NC, Falcinelli E, Cid AR, Fabris F, Fouassier M, Miyazaki K, Lozano ML, Zúñiga P, Flaujac C, Podda GM, Bermejo N, Favier R, Henskens Y, De Maistre E, De Candia E, Mumford AD, Ozdemir GN, Eker I, Nurden P, Bayart S, Lambert MP, Bussel J, Zieger B, Tosetto A, Melazzini F, Glembotsky AC, Pecci A, Cattaneo M, Schlegel N, Gresele P; European Hematology Association - Scientific Working Group (EHA-SWG) on thrombocytopenias and platelet function disorders. Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. Haematologica. 2017;102(7):1192-1203.
65) Santoro C, Sperduti I, Latagliata R, Baldacci E, Anaclerico B, Avvisati G, Breccia M, Buccisano F, Cedrone M, Cimino G, De Gregoris C, De Muro M, Di Veroli A, Leonetti Crescenzi S, Montanaro M, Montefusco E, Porrini R, Rago A, Spadea A, Spirito F, Villivà N, Andriani A, Alimena G, Mazzucconi MG. Role of treatment on the development of secondary malignancies in patients with essential thrombocythemia. Cancer Med. 2017;6(6):1233-1239.
66) Latagliata R, Montanaro M, Cedrone M, Di Veroli A, Spirito F, Santoro C, Leonetti Crescenzi S, Porrini R, Di Giandomenico J, Villivà N, Spadea A, Rago A, De Gregoris C, Romano A, Anaclerico B, De Muro M, Felici S, Breccia M, Montefusco E, Bagnato A, Cimino G, Majolino I, Mazzucconi MG, Alimena G, Andriani A; Gruppo Laziale, SMPC Ph1. High platelet count at diagnosis is a protective factor for thrombosis in patients with essential thrombocythemia. Thromb Res. 2017;156:168-171.
67) Jiang L, Liu Y, Zhang L, Santoro C, Rodriguez A. Rituximab for treating inhibitors in people with inherited severe hemophilia. Cochrane Database Syst Rev. 2017 Jul 7;7:CD010810.
68) Santoro C, Volpicelli P, Baldacci E, Ferrara G, Di Rocco A, Ferretti A, Porrazzo M, Mazzucconi MG. Repeated successful use of eltrombopag in chronic primary immune thrombocytopenia: description of an intriguing case. Clin Case Rep. 2017;5(8):1385-1388.
69) Ferretti A, Santoro C, Ferrara G, Baldacci E, Barone F, Mazzucconi MG. Anticoagulant therapy in patients with Glanzmann's Thrombasthenia: Is it possible? Haemophilia. 2017 Nov;23(6):e531-e533
70) Marchesini E, Oliovecchio E, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Iorio A, Mannucci PM. Comorbidities in persons with haemophilia aged 60 years or more compared with age-matched people from the general population. Haemophilia. 2018 Jan; 24(1):e6-e10.
72) Di Veroli A, Buccisano F, Andriani A, Montanaro M, Latagliata R, Santoro C, Breccia M, Spirito F, Cedrone M, Anaclerico B, Leonetti Crescenzi S, Porrini R, De Muro M, Avvisati G, Tafuri A, Cimino G, Spadea A. Prognostic factors for thrombosis-free survival and overall survival in polycythemia vera: A retrospective analysis of 623 PTS With long follow-up. Leuk Res. 2018 Jun;69:18-23. Epub 2018 Mar 31.
74) Santoro C, Quintavalle G, Castaman G, Baldacci E, Ferretti A, Riccardi F, Tagliaferri A. Inhibitors in Hemophilia B. Semin Thromb Hemost. 2018 Sep;44(6):578-589.
75) Mannucci P, Nobili A, Marchesini E, Oliovecchio E, Cortesi L, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre C, Zanon E, Barillari G, Cantor, I, Caimi TM, Sottilotta G, Peyvandi F, Iorio A. Rate and appropriateness of polypharmacy in older patients with hemophilia compared with age-matched controls. Accepted for publication in Haemophilia. July 2018
76) Mancuso ME, Bidlingmaier C, Mahlangu JN, Carcao M, Tosetto A; subcommittee on factor VIII, factor IX and rare coagulation disorders. The predictive value of factor VIII/factor IX levels to define the severity of hemophilia: communication from the SSC of ISTH. J Thromb Haemost. 2018 Aug
77) Coppola A, Tagliaferri A, Santoro C, Franchini M. Alloantibodies and Congenital Bleeding Disorders: New Insights in the Pathogenesis and Management. Semin Thromb Hemost. 2018 Sep;44(6):505-508.
78) Coppola A, Franchini M, Castaman G, Santagostino E, Santoro C, Santoro RC, Morfini M, Di Minno G, Rocino A; AICE ad hoc Working Group. Treatment Regimens with Bypassing Agents in Patients with Hemophilia A and Inhibitors: A Survey from the Italian Association of Hemophilia Centers (AICE). Semin Thromb Hemost. 2018 Sep;44(6):551-560.
79) Serrao A, Lucani B, Mansour D, Ferretti A, Baldacci E, Santoro C, Foà R, Chistolini A. Direct Oral Anticoagulants in Patients Affected by Major Congenital Thrombophilia. Mediterr J Hematol Infect Dis. 2019 Jul 1;11(1):e2019044
80) Napolitano M, Saccullo G, Marietta M, Carpenedo M, Castaman G, Cerchiara E, Chistolini A, Contino L, De Stefano V, Falanga A, Federici AB, Rossi E, Santoro R, Siragusa S; Gruppo Italiano Malattie EMatologiche dell’Adulto (GIMEMA) Working Party on Thrombosis and Hemostasis; Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA) Working Party on Thrombosis and Haemostasis (see Appendix 1), De Stefano V, Falanga A, Tosetto A, Avvisati G, Carpenedo M, Federici AB, Marietta M, Napolitano M, Rossi E, Santoro C, Castaman G, Cerchiara E, Chistolini A, Contino L, Mazzucconi MG, Nichele I, Russo L, Santi R, Santoro RC, Siragusa S, Tagariello G.
Platelet cut-off for anticoagulant therapy in thrombocytopenic patients with blood cancer and venous thromboembolism: an expert consensus. Blood Transfus. 2019 May;17(3):171-180.
81) Ferretti A, Baldacci E, Miulli E, Canichella M, Di Rocco A, Pulsoni A, Martelli M, Serrao A, Chistolini A, Gabriella Mazzucconi M, Foà R, Santoro C. Thrombopoietin receptor agonists to control immune thrombocytopenia in patients with active lymphoma. Br J Haematol. 2019 Sep;186(6):e217-e219.
82) Zanon E, Pasca S, Santoro C, Gamba G, Siragusa SM, Rocino A, Cantori I, Federici AB, Mameli L, Giuffrida G, Falanga A, Lodigiani C, Santoro RC, Milan M, Ambaglio C, Napolitano M, Mazzucconi MG. Activated prothrombin complex concentrate (FEIBA® ) in acquired haemophilia A: a large multicentre Italian study - the FAIR Registry. Br J Haematol. 2019 Mar;184(5):853-855.
83) Zanon E, Pasca S, Pollio B, Santagostino E, Linari S, Tagliaferri A, Santoro C, Rocino A, Marino R, Aru B, Borchiellini A, Siragusa S, Coppola A. Immune tolerance induction with moroctocog-alpha (Refacto/Refacto AF) in a population of Italian haemophilia A patients with high-titre inhibitors: Data from REF.IT Registry. Haemophilia. 2019 Oct 11.
84) Paciullo F, Bury L, Noris P, Falcinelli E, Melazzini F, Orsini S, Zaninetti C, Abdul-Kadir R, Obeng-Tuudah D, Heller P, Glembotsky AC, Fabris F, Rivera J, Lozano ML, Butta N, Favier R, Cid AR, Fouassier M, Podda GM, Santoro C, Grandone E, Henskens Y, Nurden P, Zieger B, Cuker A, Devreese K, Tosetto A, De Candia E, Dupuis A, Miyazaki K, Othman M, Gresele P. Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study. Haematologica. 2019 Sep 26.
85) von Mackensen S, Myrin Westesson L, Kavakli K, Klukowska A, Escuriola C, Uitslager N, Santoro C, Holland M, Khair K. The impact of psychosocial determinants on caregivers' burden of children with haemophilia (results of the BBC study). Haemophilia. 2019 May;25(3):424-432.
86) Bruzzese A, Santoro C, Baldacci E, Ferretti A, Pieroni S, Serrao A, Foà R, Chistolini A. Antithrombin concentrate during pregnancy in congenital antithrombin deficiency: a single-center experience. Blood Coagul Fibrinolysis. 2019 Sep;30(6):304-307.
87) Pasca S, Ambaglio C, Rocino A, Santoro C, Cantori I, Zanon E; FAIR Study Group.
Combined use of antifibrinolytics and activated prothrombin complex concentrate (aPCC) is not related to thromboembolic events in patients with acquired haemophilia A: data from FAIR Registry. J Thromb Thrombolysis. 2019 Jan;47(1):129-133.
88) Jackson S, Santoro C, Gue D, Ferretti A, Gaglioti D, Squire S, Mazzucconi MG, Hermans C. Clinical practice of personalized prophylaxis in hemophilia: Illustrations of experiences and benefits from two continents. Clin Case Rep. 2019 Feb 20;7(4):689-694.
89) Khair K, Klukowska A, Myrin Westesson L, Kavakli K, Escuriola C, Uitslager N, Santoro C, Holland M, von Mackensen S. The burden of bleeds and other clinical determinants on caregivers of children with haemophilia (the BBC Study). Haemophilia. 2019 May;25(3):416-423.
90) Porrazzo M, Baldacci E, Ferretti A, Miulli E, Chistolini A, Pecci A, Mazzucconi MG, Foà R, Santoro C.
The role of an accurate diagnosis of inherited thrombocytopenia as the basis for an effective treatment. A case of MYH9 syndrome treated with a TPO-RA. Haemophilia. 2019 Jul;25(4):e288-e290.
91) Zanon E, Pasca S, Siragusa S, Napolitano M, Santoro C, Mameli L, Rocino A; FAIR Study Group.
Low dose of aPCC after the initial treatment in acquired haemophilia A is useful to reduce bleeding relapses: Data from the FAIR registry. Thromb Res. 2019 Feb;174:24-26.
92) Santagostino E, Riva A, Cesaro S, Esposito S, Matino D, Mazzucchelli RI, Molinari AC, Mura R, Notarangelo LD, Tagliaferri A, Di Minno G, Clerici M; the HEVA Study Group.
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.Haemophilia. 2019 Jul;25(4):656-667.
93) Castaman G, Santoro C, Coppola A, Mancuso ME, Santoro RC, Bernardini S, Pugliese FR, Lubrano R, Golato M, Tripodi A, Rocino A, Santagostino E; ad hoc Working Group, Biasoli C, Borchiellini A, Catalano A, Contino L, Coluccia A, Cultrera D, De Cristofaro R, Di Minno G, Fabbri A, Franchini M, Gamba G, Giuffrida AC, Gresele P, Giampaolo A, Hassan HJ, Luciani M, Marchesini E, Marino R, Mazzucconi MG, Molinari AC, Morfini M, Notarangelo LD, Peccarisi L, Peyvandi F, Pollio B, Rivolta GF, Ruggieri MP, Sargentini V, Schiavoni M, Sciacovelli L, Serino ML, Siragusa S, Tagliaferri A, Testa S, Tosetto A, Zampogna S, Zanon E.
Emergency management in patients with haemophilia A and inhibitors on prophylaxis with emicizumab: AICE practical guidance in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET.Blood Transfus. 2020 Mar;18(2):143-151.
94) Palandri F, Santoro C, Carpenedo M, Cantoni S, Barcellini W, Carli G, Carrai V, Rossi E, Rivolti E, Lucchesi A, Rotondo F, Baldacci E, Auteri G, Sutto E, Di Pietro C, Catani L, Bartoletti D, De Stefano V, Ruggeri M, Mazzucconi MG, Cavo M, Rodeghiero F, Vianelli N.
Management of elderly patients with immune thrombocytopenia: Real-world evidence from 451 patients older than 60 years.
Thromb Res. 2020 Jan;185:88-95. doi: 10.1016/j.thromres.2019.11.026. Epub 2019 Nov 21.
95) Gresele P, Orsini S, Noris P, Falcinelli E, Alessi MC, Bury L, Borhany M, Santoro C, Glembotsky AC, Cid AR, Tosetto A, De Candia E, Fontana P, Guglielmini G, Pecci A; BAT-VAL study investigators.
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC.J Thromb Haemost. 2020 Mar;18(3):732-739.
96) Serrao A, Santoro C, Foà R, Chistolini A. Use of edoxaban for the treatment of venous thromboembolism in HIV-infected patients. HIV Med. 2020 Mar;21(3):e7. doi: 10.1111/hiv.12803. Epub 2019 Oct 16. No abstract available.
97) Zaja F, Carpenedo M, Baratè C, Borchiellini A, Chiurazzi F, Finazzi G, Lucchesi A, Palandri F, Ricco A, Santoro C, Scalzulli PR. Tapering and discontinuation of thrombopoietin receptor agonists in immune thrombocytopenia: Real-world recommendations.
Blood Rev. 2020 May;41:100647. doi: 10.1016/j.blre.2019.100647. Epub 2019 Nov 30.PMID: 31818701 Review.
98) Scamuffa MC, Morano SG, Serrao A, Bruzzese A, Stocchi F, Santoro C, Vozella F, Latagliata R, Chistolini A. PICC-related upper deep venous thrombosis in patients with hematological malignancies. Management of anticoagulant therapy according to the platelet count. J Thromb Thrombolysis. 2020 Apr;49(3):426-430.
99) De Padua V, Romeo U, Santoro C, Bosco R, Baldacci E, Ferretti A, Malaspina F, Mazzucconi MG, Gaglioti D. Dental invasive procedures in von Willebrand disease outpatients treated with high purity FVIII/VWF complex concentrate (Fanhdi®): experience of a single center.
Heliyon. 2020 Feb 25;6(2):e03426. doi: 10.1016/j.heliyon.2020.e03426. eCollection 2020 Feb.
100) Santoro C, Fuh B, Le PQ, Maes P, Berrueco R, Mingot-Castellano EM, von Mackensen S, Solms A, Wang M. BAY 81-8973 prophylaxis and pharmacokinetics in haemophilia A: Interim results from the TAURUS study. Eur J Haematol. 2020 Aug;105(2):164-172.
101) Ferretti A, Baldacci E, Chistolini A, Santoro C.Right elbow arthropathy in a patient with severe haemophilia A. Br J Haematol. 2020 May 7. doi: 10.1111/bjh.16707. Online ahead of print.
102) Mazzucconi MG, Baldacci E, Latagliata R, Breccia M, Paoloni F, Di Veroli A, Cedrone M, Anaclerico B, Villivà N, Porrini R, Montefusco E, Andriani A, Montanaro M, Scaramucci L, Spadea A, Rago A, Cimino G, Spirito F, Santoro C. Anagrelide in Essential Thrombocythemia (ET): Results from 150 patients over 25 years by the "Ph1-negative Myeloproliferative Neoplasms Latium Group". Eur J Haematol. 2020 Sep;105(3):335-343.
103) Serrao A, Fiori L, Santoro C, De Luca ML, Ferretti A, De Luca G, Ligia S, Lapietra G, Mohamed S, Breccia M, Chistolini A. Direct oral anticoagulants in patients with hematologic malignancies. Hematol Oncol. 2020 Oct;38(4):589-596.
104) Abbonizio F, Hassan HJ, Santagostino E, Arcieri R, Biffoni M, Giampaolo A; Italian Association of Haemophilia Centres; Italian Association of Haemophilia Centres. Epidemiological data and treatment strategies in children with severe haemophilia in Italy. Ann Ist Super Sanita. 2020 Oct-Dec;56(4):437-443. doi: 10.4415/ANN_20_04_05. PMID: 33346169.
105) Mazzucconi MG, Baldacci E, Ferretti A, Santoro C. Acquired Haemophilia A: An Intriguing Disease. Mediterr J Hematol Infect Dis. 2020 Jul 1;12(1):e2020045. doi: 10.4084/MJHID.2020.045. eCollection 2020.PMID: 32670523
106) Jiang L, Liu Y, Zhang L, Santoro C, Rodriguez A. Rituximab for treating inhibitors in people with inherited severe hemophilia. Cochrane Database Syst Rev. 2020 Aug 3;8:CD010810. doi: 10.1002/14651858.CD010810.pub4.
107) Chistolini A, Ruberto F, Alessandri F, Santoro C, Barone F, Puzzolo MC, Ceccarelli G, De Luca ML, Mancone M, Alvaro D, Pulcinelli FM, Martelli M, Foà R, Pugliese F; Policlinico Umberto I COVID-19 Group. Effect of low or high doses of low molecular weight heparin on thrombin generation and other hemostasis parameters in COVID-19 critical patients.
Br J Haematol. 2020 Aug;190(4):e214-e218.
108) Ferretti A, Baldacci E, Fazio F, Abbruzzese R, Barone F, De Luca ML, Petrucci MT, Chistolini A, Mazzucconi MG, Santoro C.Acquired FXIII deficiency and AL amyloidosis: A case of a rare association. Transfus Apher Sci. 2020 Dec;59(6):102903
109) Abdi A, Kloosterman FR, Eckhardt CL, Male C, Castaman G, Fischer K, Beckers EAM, Kruip MJHA, Peerlinck K, Mancuso ME, Santoro C, Hay CR, Platokouki H, van der Bom JG, Gouw SC, Fijnvandraat K, Hart DP; INSIGHT Study Group.The factor VIII treatment history of non-severe hemophilia A. J Thromb Haemost. 2020 Dec;18(12):3203-3210.
110) Serrao A, Breccia M, Napolitano M, Fiori L, Santoro M, Scalzulli E, Santopietro M, Santoro C, Raso S, Chistolini A. A multicenter real-life study on anticoagulant treatment with direct oral anticoagulants in patients with Ph negative myeloproliferative neoplasms.
Am J Hematol. 2020 Dec;95(12):E329-E332.
111) Coppola A, Castaman G, Santoro RC, Mancuso ME, Franchini M, Marino R, Rivolta GF, Santoro C, Zanon E, Sciacovelli L, Manca S, Lubrano R, Golato M, Tripodi A, Rocino A; ad hoc Working Group.Management of patients with severe haemophilia a without inhibitors on prophylaxis with emicizumab: AICE recommendations with focus on emergency in collaboration with SIBioC, SIMEU, SIMEUP, SIPMeL and SISET. Haemophilia. 2020 Nov;26(6):937-945.
112) Di Minno MND, Santoro C, Corcione A, Di Minno G, Martinelli M, Mancuso ME, Acone B, Molinari AC,
Passeri EV, Rocino A, Santoro RC, Tagliaferri A, Mattia C; HAEMODOL Study Group, Agostini P, Andreoli E, Ambaglio C, Arancio F, Aru B, Baldacci E, Belfiore A, Bernasconi S, Biasoli C, Borchiellini A, Brunetti G, Cerbone A, Caimi T, Cantori I, Coluccia A, Contino L, Coppetelli U, Costanzi M, Cultrera D, De Cristofaro R, Delios G, Di Gennaro L, Di Gregorio P, Ettorre CP, Fasulo R, Feola G, Ferretti A, Franchini M, Frizziero A, Galletti L, Giuffrida G, Giuffrida A, Iannaccaro P, Lassandro G, Linari S, Lione A, Lombardo R, Luciani M, Macchi S, Maestrini G, Malcangi G, Malizia R, Margaglione M, Marietta M, Marino R, Massoud M, Napolitano M, Nichele I, Notarangelo LD, Pagano C, Pasta G, Pollio B, Quintavalle G, Ranalli P, Raso S, Ricca I, Schiavoni M, Schiavulli M, Sottilotta G, Todisco A, Zanon E.Pain assessment and management in Italian Haemophilia Centres.
Blood Transfus. 2020 Nov 27;19(4):335-42.
113) Negri L, Buzzi A, Aru AB, Cannavò A, Castegnaro C, Fasulo MR, Lassandro G, Rocino A, Santoro C,
Sottilotta G, Giordano P, Mazzucconi MG, Mura R, Peyvandi F, Delle Fave A. Perceived well-being and mental health in haemophilia. Psychol Health Med. 2020 Oct;25(9):1062-1072.
114) Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama
Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB. Immune thrombocytopenia (ITP) World Impact Survey (I-WISh): Impact of ITP on health-related quality of life. Am J Hematol. 2021 Feb 1;96(2):199-207.
115) Cooper N, Kruse A, Kruse C, Watson S, Morgan M, Provan D, Ghanima W, Arnold DM, Tomiyama
Y, Santoro C, Michel M, Laborde S, Lovrencic B, Hou M, Bailey T, Taylor-Stokes G, Haenig J, Bussel JB. Immune thrombocytopenia (ITP) World Impact Survey (iWISh): Patient and physician perceptions of diagnosis, signs and symptoms, and treatment. Am J Hematol. 2021 Feb 1;96(2):188-198.
116) Rodeghiero F, Cantoni S, Carli G, Carpenedo M, Carrai V, Chiurazzi F, De Stefano V, Santoro C,
Siragusa S, Zaja F, Vianelli N. Practical Recommendations for the Management of Patients with ITP During the COVID-19 Pandemic. Mediterr J Hematol Infect Dis. 2021 May 1;13(1):e2021032.
117) Ruberto F, Chistolini A, Curreli M, Frati G, Marullo AGM, Biondi-Zoccai G, Mancone M, Sciarretta S,
Miraldi F, Alessandri F, Ceccarelli G, Barone F, Santoro C, Alvaro D, Pugliese F, Pulcinelli FM; Policlinico Umberto I COVID-19 Group. Von Willebrand factor with increased binding capacity is associated with reduced platelet aggregation but enhanced agglutination in COVID-19 patients: another COVID-19 paradox? J Thromb Thrombolysis. 2021 Jul;52(1):105-110.
118) Chiatamone Ranieri S, Arleo MA, Trasarti S, Bizzoni L, Carmosino I, De Luca ML, Mohamed S,
Mariggiò E, Scalzulli E, Rosati S, De Benedittis D, Colafigli G, Pepe S, Molica M, Scamuffa MC, Di Prima A, Ferretti A, Baldacci E, Mancini M, Santoro C, Vignetti M, Breccia M, Latagliata R.Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort. Clin Lymphoma Myeloma Leuk. 2021 Apr;21(4):e328-e333.
119) Eltrombopag treatment for severe immune thrombocytopenia during pregnancy: a case report.
Mendicino F, Santoro C, Martino E, Botta C, Baldacci E, Ferretti A, Muto B, Lucia E, Caracciolo D, Vigna E, Morelli M, Gentile M.Blood Coagul Fibrinolysis. 2021 Oct 1;32(7):519-521.
120) Casini A, von Mackensen S, Santoro C, Djambas Khayat C, Belhani M, Ross C, Dorgalaleh A, Naz A, Ünal E, Abdelwahab M, Lozeron ED, Trillot N, Susen S, Peyvandi F, de Moerloose P; QualyAfib Study Group. Clinical phenotype, fibrinogen supplementation, and health-related quality of life in patients with afibrinogenemia. Blood. 2021 Jun 3;137(22):3127-3136.
121) Baronciani L, Peake I, Schneppenheim R, Goodeve A, Ahmadinejad M, Badiee Z, Baghaipour MR, Benitez O, Bodó I, Budde U, Cairo A, Castaman G, Eshghi P, Goudemand J, Hassenpflug W, Hoorfar H, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Marino R, Nikšić N, Oyen F, Santoro C, Tiede A, Toogeh G, Tosetto A, Trossaert M, Zetterberg EMK, Eikenboom J, Federici AB, Peyvandi F.Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. Blood Adv. 2021 Aug 10;5(15):2987-3001.
122) Gresele P, Falcinelli E, Bury L, Pecci A, Alessi MC, Borhany M, Heller PG, Santoro C, Cid AR, Orsini S, Fontana P, De Candia E, Podda G, Kannan M, Jurk K, Castaman G, Falaise C, Guglielmini G, Noris P; BAT-VAL Study Investigators. The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology. J Thromb Haemost. 2021 May;19(5):1364-1371.
123) Lucchini E, Palandri F, Volpetti S, Vianelli N, Auteri G, Rossi E, Patriarca A, Carli G, Barcellini W, Celli M, Consoli U, Valeri F, Santoro C, Crea E, Vignetti M, Paoloni F, Gigliotti CL, Boggio E, Dianzani U, Giardini I, Carpenedo M, Rodeghiero F, Fanin R, Zaja F; for Gruppo Italiano Malattie Ematologiche dell’Adulto (GIMEMA). Eltrombopag second-line therapy in adult patients with primary immune thrombocytopenia in an attempt to achieve sustained remission off-treatment: results of a phase II, multicentre, prospective study. Br J Haematol. 2021 Apr;193(2):386-396.
124) Franchini M, Coppola A, Santoro C, De Cristofaro R, Barillari G, Giordano P, Gresele P, Lassandro G, Napolitano M, Lucchini G, Luciani M, Ferretti A, Baldacci E, Riccardi F, Santoro RC, Pasca S, Zanon E, Tagliaferri A. ABO Blood Group and Inhibitor Risk in Severe Hemophilia A Patients: A Study from the Italian Association of Hemophilia Centers. Semin Thromb Hemost. 2021 Feb;47(1):84-89.
125) Riva S, Marchesini E, Oliovecchio E, Coppola A, Santagostino E, Radossi P, Castaman G, Valdrè L, Santoro C, Tagliaferri A, Ettorre CP, Zanon E, Barillari G, Cantori I, Caimi TM, Sottilotta G, Iorio A, Mannucci PM. Comparison of quality of life, and emotional and functional profiles in older people with and without severe haemophilia. Haemophilia. 2021 Jul;27(4):e525-e529. doi: 10.1111/hae.14268. Epub 2021 Feb 4. PMID: 33538374.
126) Porrazzo M, Baldacci E, Ferretti A, De Luca ML, Barone F, Serrao A, Aprile SM, Capria S, Minotti C, Martelli M, Mazzucconi MG, Chistolini A, Santoro C. Single centre experience on Acquired Haemophilia A patients: Diagnosis, clinical management and analysis of factors predictive of response and outcome. Haemophilia. 2021 Nov;27(6):e667-e674.
127) Coluccia A, Marchesini E, Giuffrida AC, Rivolta GF, Ricca I, Zanon E, Luciani M, De Cristofaro R, Coppola A, Rocino A; AICE MECCOVID-19 Study Group. Addressing the impact of SARS-CoV-2 infection in persons with congenital bleeding disorders: The Italian MECCOVID-19 study. Haemophilia. 2021 Jul;27(4):e575-e578.
128) Cristina Mancarella , Alessandra Marini, Rocco Severino, Paolo Missori, Cristina Santoro, and Sergio Paolini. Factor XI deficiency and delayed hemorrhages after resection of choroid plexus papilloma: illustrative case. Journal of Neurosurgery: case Lessons. Dec 2021. DOI link: https://doi.org/10.3171/CASE21333
129) Santoro C, Di Minno MND, Corcione A, Di Minno G, Martinelli M, Mancuso ME, Acone B, Molinari AC, Passeri EV, Rocino A, Santoro RC, Tagliaferri A, Mattia C; HAEMODOL Study Group. Improving assessment and management of pain in hemophilia: an Italian Delphi consensus statement. Blood Rev. 2022 Jan;51:100885.
130) Cortesi PA, Rocino A, Preti D, Fragomeno A, Cucuzza F, Ceresi N, Santoro C, Ferretti A, Fornari A, Antonazzo IC, Facchetti R, Cozzolino P, Biasoli C, Cassone C, Coppola A, Mantovani LG. Haemophilia management and treatment: An Italian survey on patients', caregivers' and clinicians' point of view. Haemophilia. 2022 Mar;28(2):254-263.
131) Lapietra G, Ferretti A, Baldacci E, Chistolini A, Santoro C. Immune thrombocytopenia management during COVID-19 pandemic: An Italian monocentric experience.
EJHaem. 2022 Mar 9;3(2):453-456.
132) Pagliari MT, Rosendaal FR, Ahmadinejad M, Badiee Z, Baghaipour MR, Baronciani L, Benítez Hidalgo O, Bodó I, Budde U, Castaman G, Eshghi P, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Mannucci PM, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Peyvandi F, Federici AB, Eikenboom J. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS-IPS study. J Thromb Haemost. 2022 May;20(5):1106-1114.
133) Capuano C, Pighi C, Battella S, Pulcinelli F, Santoro C, Ferretti A, Turriziani O, De Federicis D, Fionda C, Sciumè G, Galandrini R, Palmieri G. (Auto)Antibody Responses Shape Memory NK Cell Pool Size and Composition. Biomedicines. 2022 Mar 8;10(3):625.
134) Branchini A, Morfini M, Lunghi B, Belvini D, Radossi P, Bury L, Serino ML, Giordano P, Cultrera D, Molinari AC, Napolitano M, Bigagli E, Castaman G, Pinotti M, Bernardi F; GePKHIS Study Group of AICE. F9 missense mutations impairing factor IX activation are associated with pleiotropic plasma phenotypes. J Thromb Haemost. 2022 Jan;20(1):69
135) Serrao A, Malfona F, Assanto GM, Orellana MGC, Santoro C, Chistolini A. Direct oral anticoagulants for the treatment of atrial fibrillation in patients with hematologic malignancies. J Thromb Thrombolysis. 2022 Nov;54(4):625-629.
136) Borchiellini A, Castaman G, Feola G, Ferretti A, Giordano P, Luciani M, Malcangi G, Margaglione M, Molinari AC, Pollio B, Rocino A, Santoro C, Schiavulli M, Zanon E. Italian experience with rVIII-single chain: a survey of patients with haemophilia A and their physicians. J Thromb Thrombolysis. 2022 May;53(4):934-944.
137) Coppola A, Franchini M, Tripodi A, Santoro RC, Castaman G, Marino R, Zanon E, Santoro C, Rivolta GF, Contino L, De Cristofaro R, Molinari AC, Gresele P, Rocino A; ad hoc Working Group (Appendix 1). Acquired haemophilia A: Italian Consensus Recommendations on diagnosis, general management and treatment of bleeding. Blood Transfus. 2022 May;20(3):245-262.
138) Coppola A, Franchini M, Pappagallo G, Borchiellini A, De Cristofaro R, Molinari AC, Santoro RC, Santoro C, Tagliaferri A. Current Choices and Management of Treatment in Persons with Severe Hemophilia A without Inhibitors: A Mini-Delphi Consensus. J Clin Med. 2022 Feb 2;11(3):801.
139) Di Minno G, Coppola A, Margaglione M, Rocino A, Mancuso ME, Tagliaferri A, Linari S, Zanon E, Santoro C, Biasoli C, Castaman G, Santagostino E, Mannucci PM; AICE PROFIT Study Group. Predictors of inhibitor eradication by primary immune tolerance induction in severe haemophilia A with high responding inhibitors. Haemophilia. 2022 Jan;28(1):55-64.
140) Zanon E, Pasca S, Demartis F, Tagliaferri A, Santoro C, Cantori I, Molinari AC, Biasoli C, Coppola A, Luciani M, Sottilotta G, Ricca I, Pollio B, Borchiellini A, Tosetto A, Peyvandi F, Frigo AC, Simioni P. Intracranial Haemorrhage in Haemophilia Patients Is Still an Open Issue: The Final Results of the Italian EMO.REC Registry. J Clin Med. 2022 Apr 1;11(7):1969.
141) Di Minno MND, Napolitano M, Giuffrida AC, Baldacci E, Carulli C, Boccalandro E, Bruno C, Forneris E, Ricca I, Passeri W, Martinelli M, Rivolta GF, Solimeno LP, Martinoli C, Rocino A, Pasta G; Italian Association of Haemophilia Centres Musculoskeletal Working Group. Diagnosis and treatment of chronic synovitis in patients with haemophilia: consensus statements from the Italian Association of Haemophilia Centres. Br J Haematol. 2022 Feb;196(4):871-883.
142) Serrao A, Assanto GM, Mormile R, Brescini M, Santoro C, Chistolini A. Secondary prophylaxis of venous thromboembolism with direct oral anticoagulants: comparison between patients with major congenital thrombophilia versus non-thrombophilic patients. Intern Emerg Med. 2022 Jun;17(4):1081-1085.
143) Di Minno G, Spadarella G, Maldonato NM, De Lucia N, Castaman G, De Cristofaro R, Santoro C, Peyvandi F, Borrelli A, Lupi A, Follino M, Guerrino G, Morisco F, Di Minno M. Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline. Blood Rev. 2023 Aug 1:101118.
144) Castaman G, Carulli C, De Cristofaro R, Follino M, Lupi A, Mancuso ME, Mansueto MF, Molinari AC, Pasquetti P, Santoro C, Santoro RC, Siragusa S, Solimeno LP, Tripodi A, Zanon E, Minno GD. Laying the foundations for gene therapy in Italy for patients with haemophilia A: A Delphi consensus study. Haemophilia. 2023 Mar;29(2):435-444.
145) D'Alberti E, Brunelli R, D'Ambrosio V, Galoppi P, Santoro C, Giancotti A. Severe maternal thrombocytopenia and prenatal invasive procedures: still a grey zone. J Perinat Med. 2023 Apr 18;51(7):861-864.
146) Coppola A, Rocino A, Santoro RC, Molinari AC, Santoro C, Zanon E. XVIII Convegno Triennale sui Problemi Clinici e Sociali dell'Emofilia, Napoli, 12-15 ottobre 2023.Blood Transfus. 2023 Oct 12. Suppl4.
147) Stefanini L, Ruberto F, Curreli M, Chistolini A, Schiera E, Marrapodi R, Visentini M, Ceccarelli G, D'Ettorre G, Santoro C, Gandini O, Moro EF, Zullino V, Pugliese F, Pulcinelli FM. Increased von Willebrand Factor Platelet-Binding Capacity Is Related to Poor Prognosis in COVID-19 Patients. Thromb Haemost. 2023 Jan;123(1):118-122.
148) Ligia S, Musiu P, Serrao A, Santoro C, Taglietti A, Capriata M, Faccini A, Molinari MC, Baldacci E, Chistolini A. Low-dose apixaban or rivaroxaban as secondary prophylaxis of upper extremity deep vein thrombosis. J Thromb Thrombolysis. 2023 Aug;56(2):323-326.
149) Zanon E, De Cristofaro R, Franchini M, Morfini M, Pasut G, Molinari AC, Santoro C, Santoro RC, Coppola A, Rocino A. Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia Centers. Blood Transfus. 2023 Sep;21(5):441-451.
150) Pagliari MT, Budde U, Baronciani L, Eshghi P, Ahmadinejad M, Badiee Z, Baghaipour MR, Hidalgo OB, Biguzzi E, Bodó I, Castaman G, Goudemand J, Karimi M, Keikhaei B, Lassila R, Leebeek FWG, Lopez Fernandez MF, Marino R, Oldenburg J, Peake I, Santoro C, Schneppenheim R, Tiede A, Toogeh G, Tosetto A, Trossaert M, Yadegari H, Zetterberg EMK, Mannucci PM, Federici AB, Eikenboom J, Peyvandi F. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS. J Thromb Haemost. 2023 Apr;21(4):787-799.
151) Pasca S, Linari S, Tagliaferri A, Santoro C, Zanon E; EMO.REC study group. Very high risk of intracranial hemorrhage and severe outcomes in adult patients with mild hemophilia: Sub-analysis of the EMO.REC Registry. Thromb Res. 2023 Jan;221:35-36.
152) Chistolini A, Serrao A, Assanto GM, Genoese A, Baldacci E, Ligia S, Breccia M, Santoro C. Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients. Ann Hematol. 2023 Sep;102(9):2599-2605.
153) Santoro C, Fuh B, Le PQ, Maes P, Berrueco R, Mingot-Castellano EM, von Mackensen S, Tueckmantel C, Cabre-Marquez JF, Wang M. Efficacy and safety in patients with haemophilia A switching to octocog alfa (BAY 81-8973): Final results of the global real-world study, TAURUS. Eur J Haematol. 2023 Jan;110(1):77-87
154) Napolitano M, Vianelli N, Ghiotto L, Cantoni S, Carli G, Carpenedo M, Carrai V, Consoli U, Giuffrida G, Lucchini E, Rossi E, Santoro C, Rodeghiero F. Nationwide Survey on the Use of Thrombopoietin Receptor Agonists (TPO-RA) for the Management of Immune Thrombocytopenia in Current Clinical Practice in Italy. Mediterr J Hematol Infect Dis. 2023 Mar 1;15(1):e2023019
155) Tagliaferri A, Molinari AC, Peyvandi F, Coppola A, Demartis F, Biasoli C, Borchiellini A, Cultrera D, De Cristofaro R, Daniele F, Giordano P, Marchesini E, Margaglione M, Marino R, Pollio B, Radossi P, Santoro C, Santoro RC, Siragusa S, Sottilotta G, Tosetto A, Piscitelli L, Villa MR, Zanon E, Finardi A, Schiavetti I, Vaccari D, Castaman G. IDEAL study: A real-world assessment of pattern of use and clinical outcomes with recombinant coagulation factor IX albumin fusion protein (rIX-FP) in patients with haemophilia B in Italy. Haemophilia. 2023 Jan;29(1):135-144.
156) Antonazzo IC, Cortesi PA, Zanon E, Pasca S, Morfini M, Santoro C, De Cristofaro R, Di Minno G, Cozzolino P, Mantovani LG.Medicina (Kaunas). Personalized Prophylaxis with myPKFiTCE: A Real-World Cost-Effectiveness Analysis in Haemophilia A Patients. 2023 Dec 24;60(1):34. doi: 10.3390/medicina60010034.
157) Fornari A, Antonazzo IC, Rocino A, Preti D, Fragomeno A, Cucuzza F, Ceresi N, Santoro C, Ferretti A, Facchetti R, Cozzolino P, Biasoli C, Cassone C, Coppola A, Cortesi PA, Mantovani LG. The psychosocial impact of haemophilia from patients' and caregivers' point of view: The results of an Italian survey. Haemophilia. 2023 Dec 26. doi: 10.1111/hae.14926. Online ahead of print.
158) Mazzucconi MGG, Rodeghiero F, Avvisati G, De Stefano V, Gugliotta L, Ruggeri M, Vianelli N, Fazi P, Paoloni F, Sargentini V, Baldacci E, Ferretti A, Martino B, Vincelli ID, Carli G, Fortuna S, Di Ianni M, Ranalli P, Palandri F, Polverelli N, Lugli E, Rivolti E, Patriarca A, Rago A, D'Adda M, Gentile M, Siragusa S, Sibilla S, Carella AM, Rossi E, Battistini R, Zaja F, Bocchia M, Di Renzo N, Musto P, Crugnola M, Giuffrida AC, Krampera M, Tafuri A, Santoro C. Prednisone vs high-dose dexamethasone in newly diagnosed adult primary Immune Thrombocytopenia: a randomised trial. Blood Adv. 2024 Jan 17:bloodadvances.2023010975. doi:10.1182/bloodadvances.2023010975. Online ahead of print.PMID: 38231017
159) Casini A, Abdul Kadir R, Abdelwahab M, Manco-Johnson MJ, Raut S, Ross C, de Moerloose P, Santoro C, Acharya S.J Management of pregnancy and delivery in congenital fibrinogen disorders: communication from the ISTH SSC Subcommittee on Factor XIII and Fibrinogen. Thromb Haemost. 2024 Jan 22:S1538-7836(24)00045-X. doi: 10.1016/j.jtha.2024.01.008. Online ahead of print.
160) Passucci M, Laganà A, Donzelli L, Masucci C, Genoese A, Chistolini A, Baldacci E, Santoro C. Fostamatinib combined with TPO-RAs or steroids as a bridge to monotherapy or as time-limited continuous treatment in relapsed chronic ITP: A single-centre case series. Br J Haematol. 2024 Apr 2. doi: 10.1111/bjh.19450. Online ahead of print.
161) Federici AB, Santoro RC, Santoro C, Pieri L, Santi RM, Barillari G, Borchiellini A, Tosetto A, Zanon E,
De Cristofaro R, Mairal E, Mir R. Real-World Efficacy and Safety of Plasma-Derived Von Willebrand
Factor-Containing Factor VIII Concentrates in Patients With Von Willebrand Disease in Italy. Clin Appl
Thromb Hemost. 2024 Jul 21:10760296241264541. doi: 10.1177/10760296241264541. Epub ahead of print. PMID: 39033425.
162) Fattizzo B, Carrai V, Crugnola M, Baldacci E, Bellini M, Bosi C, Buzzatti E, Caramazza D, Carli G, Carpenedo M, Clissa C, Danesin C, De Paolis MR, Giannotta JA, Innao V, Marchetti M, Markovic U, Morotti A, Napolitano M, Patriarca A, Pettine L, Poloni A, Rivolti E, Rossi E, Santeremo TM, Santoro C, Zannier ME, Zaja F, Cantoni S, Palandri F, De Stefano V. Evans syndrome: Disease awareness and clinical management in a nation-wide ITP-NET survey. Eur J Haematol. 2024 Jun 21. doi: 10.1111/ejh.14256. Epub ahead of print. PMID: 39031658.
163) Laganà A, Assanto GM, Passucci M, Santoro C, Chistolini A. Evaluation of VTE- PREDICT Risk Score in Patients Receiving Low-Dose DOACs for Venous Thromboembolism (VTE) Secondary Prophylaxis. Mediterr J Hematol Infect Dis. 2024 May 1;16(1):e2024047. doi: 10.4084/MJHID.2024.047. PMID: 38882449; PMCID: PMC11178042.
164) Laganà A, Assanto GM, Masucci C, Passucci M, Donzelli L, Serrao A, BaldacciE, Santoro C, Chistolini A. Secondary Prophylaxis of Venous Thromboembolism (VTE) with Low Dose Apixaban or Rivaroxaban: Results from a Patient Population with More than 2 Years of Median Follow-up. Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024020. doi: 10.4084/MJHID.2024.020. PMID: 38468835; PMCID: PMC10927198.
165) Paciullo F, Momi S, Mancuso ME, Santoro C, Napolitano M, Castaman G, Zanon E, Contino L, De Cristofaro R, Santoro RC, Gresele P. Effect of statin intake on FVIII levels and bleeding outcomes in hypercholesterolemic patients with hemophilia A. Thromb Res. 2024 Apr;236:167-169. doi:
10.1016/j.thromres.2024.02.028. Epub 2024 Mar 2. PMID: 38457995.
166) Giordano P, Pollio B, Sottilotta G, Biasoli C, Daniele F, De Cristofaro R, Peyvandi F, Villa MR, Castaman G; IDEAL Study Group. Pattern of use and clinical outcomes with rIX-FP in pediatric/adolescent patients with haemophilia B in Italy: Results from IDEAL real-world study. Eur J Haematol. 2024 May;112(5):765-775. doi: 10.1111/ejh.14168. Epub 2024 Jan 15. PMID: 38223989.
167) Massimo Morfini 1,* , Flora Peyvandi, Maria Elisa Mancuso 3 Emanuela Marchesini 4 Annarita Tagliaferri 5 Roberta Gualtierotti 2Giancarlo Castaman 6Berardino Pollio 7Cristina Santoro 8Luisa Banov 9Mariasanta Napolitano 10, Paola Stefania Preti 11, Roberta Carlotta Santoro 12 , Antonio Coppola 5Silvia Linari 6 Elena Santagostino 13 and Francesco Bernardi 14Pharmacokinetics of Efmoroctocog alfa by Two-Compartment Model Highlights Hemophilia A Patients with Biphasic Decay, Long Mean Residence Time, and Beta Half-Life. J. Clin. Med. 2024, 13, 4986. https://doi.org/10.3390/jcm13174986.
168) Antonio Fabozzi 1*, Gianluca Paciucci 1*, Emma Repaci 1 , Alessandra Iacovelli 1 , Luigi Panza1 , Ambra Migliarini1 , Cristina Santoro2 , Paolo Palange 1. Hemophagocytic lymphohistiocytosis and pulmonary embolism caused by bacillus Calmette-Guerin intravesical instillation. Acta Biomed 2024; Vol. 95, N. 4: e2024104
Monografie e Manuali
a) Monografia "La Piastrinopenia Autoimmune", Collana Grandangolo in Ematologia. Direttori della Collana: Franco Mandelli, Giuseppe Avvisati. (con Prof.ssa Maria Gabriella Mazzucconi) (2001)
b) Manuale di Ematologia "Ematologia di Mandelli”, a cura di Giuseppe Avvisati, Seconda edizione, PICCIN (Capitoli “Trombocitopenie” con Erminia Baldacci, e “Coagulopatie” con Antonio Chistolini) (2019)
c) Manuale di "Clinica e terapia delle malattie Emorragiche e Trombotiche”, a cura di Giancarlo Castaman e Anna Falanga, PICCIN (Capitolo “I disordini congeniti del Fibrinogeno”, con Prof.ssa Flora Peyvandi) (2018)
d) Manuale "Percorsi diagnostici in ematologia”, a cura di Umberto Recine, Angela Rago, Tommaso Caravita di Toritto, Claudio Gambetta, Società Editrice Universo (Capitolo “Piastrinopenia” con Umberto Recine e Claudio Gambetta e “Disturbi dell’emostasi e della coagulazione”) (2023)